Evidence map›Paper›PMID 40020043›Full record

ArticleJMIR public health and surveillance2025

Mpox Prevention Self-Efficacy and Associated Factors Among Men Who Have Sex With Men in China: Large Cross-Sectional Study.

Quyige Gao, Shangbin Liu, Muzaibaier Tuerxunjiang, Huifang Xu, Jiechen Zhang, Gang Xu, Jianyu Chen, Yong Cai, Fan Hu, Ying Wang

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Quyige Gao *Dermatology Department, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0009-0003-4237-8482
Shangbin Liu *Public Health Research Center, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xianxia Road, Changning District, Shanghai, 200335, China, 86 021-52039999.ORCID 0000-0001-9455-5282
Muzaibaier TuerxunjiangSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0009-0008-0032-9144
Huifang XuSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-9088-5169
Jiechen ZhangDermatology Department, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-5256-8672
Gang XuSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0001-9636-4658
Jianyu ChenCollege of Public Health, Shanghai University of Medicine and Health Sciences, Shanghai, China.ORCID 0009-0000-0513-1411
Yong CaiInstitute of Community Medical Research, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-5706-7906
Fan HuHongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-7929-6953
Ying WangPublic Health Research Center, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xianxia Road, Changning District, Shanghai, 200335, China, 86 021-52039999.ORCID 0000-0002-6036-4135

Funding

Modulation of Gut-Brain Axis Using Fecal Microbiome Transplant Capsules in CirrhosisR21TR002024 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2017 to 2018
$414k
NCATS NIH HHS R21 TR002024
6 · The paper itself

Abstract

Background: Self-efficacy in mpox (formerly known as monkeypox) prevention plays a pivotal role in promoting preventive behaviors by fostering a sense of control and motivation, especially among men who have sex with men (MSM), the population most affected by mpox in many countries. Objective: This study aims to assess the mpox prevention self-efficacy among MSM in China and identify factors influencing it, using a validated mpox prevention self-efficacy scale. Methods: From October 2023 to March 2024, a nationwide cross-sectional study was conducted among MSM (aged ≥18 years) across 6 geographic regions in China using a snowball sampling method. The recruited participants (effective response rate=2403/2481, 96.9%) were asked to complete an anonymous questionnaire designed based on prior knowledge of mpox and social cognitive theory. The mpox prevention self-efficacy scale was evaluated for construct validity using exploratory factor analysis and confirmatory factor analysis, and its reliability was assessed using the Cronbach α coefficient. Univariate and multivariable logistic regression analyses were used to examine the factors associated with mpox prevention self-efficacy among MSM. Results: A total of 2403 MSM participants were included, with a mean age of 29 (IQR 19-39) years. Of these, 1228 (51.1%) were aged 25-34 years, 1888 (78.6%) held a college degree or higher, and 2035 (84.7%) were unmarried. The median mpox prevention self-efficacy score was 23 (IQR 18-28). Exploratory factor analysis retained 6 items of the mpox prevention self-efficacy scale. Confirmatory factor analysis confirmed a strong model fit (χ²₅=32.1, n=1225; P<.001; comparative fit index=0.991; root mean square error of approximation=0.067; standardized root mean square residual=0.02; goodness-of-fit index=0.992; normed fit index=0.990; incremental fit index=0.991; Tucker-Lewis index=0.974), with all indices within acceptable ranges. The scale demonstrated good internal consistency, with a Cronbach α of 0.859. The positive factors associated with mpox prevention self-efficacy were mpox-related knowledge (OR 1.107, 95% CI 1.070-1.146), perceived risk awareness (OR 1.338, 95% CI 1.132-1.583), and mpox risk perception (OR 1.154, 95% CI 1.066-1.250), while the negative factor was age, with individuals aged 25 years and older exhibiting lower self-efficacy in mpox prevention (25-34 years: OR 0.789, 95% CI 0.642-0.970; 35-44 years: OR 0.572, 95% CI 0.444-0.736; 45 years and older: OR 0.569, 95% CI 0.394-0.823). Conclusions: These findings highlight the critical role of targeted interventions to enhance mpox prevention self-efficacy, particularly through increasing knowledge, perceived risk awareness, and risk perception. Such interventions are especially important for middle-aged and older MSM, who may experience a decline in self-efficacy. Strengthening self-efficacy in these areas is essential for promoting sustained preventive behaviors, improving mental well-being, and contributing to more effective mpox prevention and control within the MSM community.

Indexed as

Homosexuality, MaleSelf EfficacyAdolescentAdultChinaCross-Sectional StudiesHumansMaleMiddle AgedMpox, MonkeypoxSurveys and QuestionnairesYoung Adultcross-sectional studymen who have sex with menmonkeypoxmpoxmpox prevention self-efficacy scaleMSMself-efficacy

Identifiers

PMID40020043
PMCPMC11887935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.